Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19 — CARL H. JUNE (UNIVERSITY OF PEN
OVERALL PROJECT SUMMARY / ABSTRACT The long-term goals of this renewal P01 are to develop next generation immunotherapy with chimeric antigen receptor (CAR) T cells and to translate this research into
| Project title | Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19 |
|---|---|
| Project number | 2P01CA214278-06A1 |
| PI name | CARL H. JUNE |
| Institution | UNIVERSITY OF PENNSYLVANIA |
| Funding mechanism | P01 |
| Agency | NCI |
| Award amount | $2.78M |
| Fiscal year | 2023 |
| Project start | 2017-08-15T00:00:00 |
| Project end | 2028-08-31T00:00:00 |
| Abstract | OVERALL PROJECT SUMMARY / ABSTRACT The long-term goals of this renewal P01 are to develop next generation immunotherapy with chimeric antigen receptor (CAR) T cells and to translate this research into |
| Key terms | <AML - Acute Myeloid Leukemia><Acute B-Lymphocytic Leukemia><Acute Myeloblastic Leukemia><Acute Myel |
$799/mo
Try GrantRadar →